MedPath

Fonkomustin

Brand Name: Fonkomustin

Generic Name: Bendamustine Hydrochloride (as monohydrate)

Active
Registration Number

DRP-12247

Dosage Form

Lyophilized Powder For Injection (IV)

Issuance Date

July 1, 2022

Expiry Date

July 1, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 mg
PackagingUSP Type I amber glass vial with grey bromo butyl rubber stopper and blue flip off seal x 20 mL (Box of 1’s)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic (Nitrogen Mustard Analogue)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Bendamustine Hydrochloride (as monohydrate)Active
Monograph: bendamustine hydrochloride (as monohydrate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform